Stockholders' Equity (Details Narrative) - USD ($) |
6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Jun. 18, 2020 |
Sep. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 25, 2020 |
Jun. 24, 2020 |
Dec. 31, 2019 |
|
| Common stock, shares authorized | 30,000,000 | 30,000,000 | 100,000,000 | 100,000,000 | |||
| Preferred stock, shares issued | |||||||
| Preferred stock, shares outstanding | |||||||
| Pledge Agreement with PoC [Member] | |||||||
| Clinical trial funding commitment | $ 1,800,000 | ||||||
| Reduced clinical trial funding commitment | $ 900,000 | ||||||
| Number of pledged shares forfeited | 56,640 | ||||||
| Warrants to purchase common stock, forfeited | 56,640 | ||||||
| 2018 Private Placement Transactions [Member] | |||||||
| Debt conversion price per share | $ 14.28 | ||||||
| Number of common stock issued during period | 28,971 | 28,971 | 28,971 | ||||
| X | ||||||||||
- Definition Warrants to purchase common stock, forfeited. No definition available.
|
| X | ||||||||||
- Definition Clinical Trial Funding commitment in reduction for subscription receivable. No definition available.
|
| X | ||||||||||
- Definition Number of pledged shares forfeited. No definition available.
|
| X | ||||||||||
- Definition Reduced clinical trial funding commitment. No definition available.
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|